BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $10,281,000 | +16.9% | 100,000 | 0.0% | 0.23% | +28.5% |
Q2 2021 | $8,796,000 | -79.5% | 100,000 | -81.8% | 0.18% | -85.1% |
Q2 2020 | $42,900,000 | +22.3% | 550,000 | -8.3% | 1.20% | -19.1% |
Q1 2020 | $35,088,000 | -12.4% | 600,000 | +20.0% | 1.48% | -4.1% |
Q4 2019 | $40,055,000 | -9.1% | 500,000 | -16.7% | 1.55% | -12.5% |
Q3 2019 | $44,082,000 | -37.7% | 600,000 | -20.0% | 1.77% | -38.2% |
Q2 2019 | $70,748,000 | +4.0% | 750,000 | -11.8% | 2.86% | +3.0% |
Q1 2019 | $68,043,000 | +110.4% | 850,000 | +41.7% | 2.78% | +131.9% |
Q4 2018 | $32,346,000 | -17.1% | 600,000 | +20.0% | 1.20% | +18.0% |
Q3 2018 | $39,030,000 | -31.7% | 500,000 | -44.4% | 1.02% | -16.4% |
Q2 2018 | $57,132,000 | +24.6% | 900,000 | +80.0% | 1.21% | +111.9% |
Q1 2018 | $45,850,000 | +508.0% | 500,000 | +400.0% | 0.57% | +402.6% |
Q4 2017 | $7,541,000 | – | 100,000 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |